Clinical Trial

MFinity BE Pre-market Trial

Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
The primary objective of this trial is to determine the implant survival at 1 year of follow up in a population of patients undergoing primary Total Hip Replacement with MFinity Collared Femoral stem and to test its non-inferiority compared to other cementless implant (as reported by the EPRD registry).
Trial Details
NCT Number NCT07616895
Lead Sponsor Medacta International SA
Conditions Total Hip Arthroplasty (THA)
Enrollment 95 participants
Start Date 2026-06
Primary Completion 2028-06 (estimated)
Study Completion 2029-06 (estimated)
Updated on ClinicalTrials.gov 2026-06-01